Literature DB >> 22711434

Long-term risk projection and its application to nephrology research.

Tanvir Chowdhury Turin1, Brenda R Hemmelgarn.   

Abstract

Measures of kidney disease burden or risk estimates in nephrology research have primarily focused on the concepts of prevalence, annual incidence or relatively short-term risk such as five or ten-year risk. The concept of long-term risk is rarely used in nephrology research. This paper focuses on two long-term risk measures-lifetime risk and life expectancy. Lifetime risk is an epidemiologic measure that expresses the probability that a person who is currently free of the condition will acquire it at some time during the remainder of their expected lifespan. Life expectancy is the expected number of years of life remaining for a given group of individuals at a specified age. Key data required for estimation of lifetime risk and life expectancy are disease incidence and mortality derived by considering age in the time scale in a longitudinal study. Lifetime risks can be estimated from incidence and mortality rates derived from prospective studies whereas mortality rates are required to estimate life expectancy. Although short-term risks are important, long-term risk can be particularly beneficial for future prediction of the burden of kidney disease, and to assist in health planning and public education.

Entities:  

Mesh:

Year:  2012        PMID: 22711434     DOI: 10.5301/jn.5000197

Source DB:  PubMed          Journal:  J Nephrol        ISSN: 1121-8428            Impact factor:   3.902


  6 in total

1.  Lifetime risk of diabetes among First Nations and non-First Nations people.

Authors:  Tanvir Chowdhury Turin; Nathalie Saad; Min Jun; Marcello Tonelli; Zhihai Ma; Cheryl Carmelle Marie Barnabe; Braden Manns; Brenda Hemmelgarn
Journal:  CMAJ       Date:  2016-09-19       Impact factor: 8.262

2.  Impact of hypertension on the lifetime risk of coronary heart disease.

Authors:  Tanvir Chowdhury Turin; Tomonori Okamura; Arfan Raheen Afzal; Nahid Rumana; Makoto Watanabe; Aya Higashiyama; Yoko M Nakao; Michikazu Nakai; Misa Takegami; Kunihiro Nishimura; Yoshihiro Kokubo; Akira Okayama; Yoshihiro Miyamoto
Journal:  Hypertens Res       Date:  2016-03-10       Impact factor: 3.872

3.  Lifetime incidence of CKD stages 3-5 in the United States.

Authors:  Morgan E Grams; Eric K H Chow; Dorry L Segev; Josef Coresh
Journal:  Am J Kidney Dis       Date:  2013-04-06       Impact factor: 8.860

4.  Kidney function, albuminuria and life expectancy.

Authors:  Tanvir Chowdhury Turin; Sofia B Ahmed; Marcello Tonelli; Braden Manns; Pietro Ravani; Matthew James; Robert R Quinn; Min Jun; Ron Gansevoort; Brenda Hemmelgarn
Journal:  Can J Kidney Health Dis       Date:  2014-12-19

Review 5.  The role of an out-patient renal clinic in renal disease management.

Authors:  Eva Kiousi; Eirini Grapsa
Journal:  J Transl Int Med       Date:  2015-03-30

6.  Chinese primary knee osteoarthritis progression cohort (CPKOPC) to evaluate the progression of knee osteoarthritis in the Beijing population: a prospective cohort study protocol.

Authors:  Minwei Zhao; Yupeng Liang; Xinguang Wang; Lin Zeng; Hua Tian
Journal:  BMJ Open       Date:  2019-08-20       Impact factor: 2.692

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.